150 related articles for article (PubMed ID: 26073250)
1. Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
Mizumura N; Demura K; Kawasaki M; Okumura S; Toyoda S; Imagawa A; Ogawa M; Ohba K; Kameyama M
Intern Med; 2015; 54(12):1559-62. PubMed ID: 26073250
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile associated diarrhoea: diagnosis and treatment.
Starr J
BMJ; 2005 Sep; 331(7515):498-501. PubMed ID: 16141157
[TBL] [Abstract][Full Text] [Related]
3. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
4. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.
El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB
Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
de Lalla F; Nicolin R; Rinaldi E; Scarpellini P; Rigoli R; Manfrin V; Tramarin A
Antimicrob Agents Chemother; 1992 Oct; 36(10):2192-6. PubMed ID: 1444298
[TBL] [Abstract][Full Text] [Related]
7. Length of vancomycin administration for treatment of clostridium difficile-associated diarrhea may depend on presentation of colonic ulcer.
Yamashita M; Nomura K; Fujimoto Y; Morimoto Y; Ohshiro M; Tsutsumi Y; Kobayashi T; Kaneko H; Yasuhawa S; Yanagisawa A; Toshikazu Y; Masafumi T;
Hepatogastroenterology; 2009; 56(90):313-6. PubMed ID: 19579589
[TBL] [Abstract][Full Text] [Related]
8. Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
Apisarnthanarak A; Khoury H; Reinus WR; Crippin JS; Mundy LM
Am J Med; 2002 Mar; 112(4):328-9. PubMed ID: 11893379
[No Abstract] [Full Text] [Related]
9. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
10. Duodenal infusion of donor feces for recurrent Clostridium difficile.
van Nood E; Vrieze A; Nieuwdorp M; Fuentes S; Zoetendal EG; de Vos WM; Visser CE; Kuijper EJ; Bartelsman JF; Tijssen JG; Speelman P; Dijkgraaf MG; Keller JJ
N Engl J Med; 2013 Jan; 368(5):407-15. PubMed ID: 23323867
[TBL] [Abstract][Full Text] [Related]
11. Intracolonic vancomycin for severe Clostridium difficile colitis.
Kim PK; Huh HC; Cohen HW; Feinberg EJ; Ahmad S; Coyle C; Teperman S; Boothe H
Surg Infect (Larchmt); 2013 Dec; 14(6):532-9. PubMed ID: 23560732
[TBL] [Abstract][Full Text] [Related]
12. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
Saffouri G; Khanna S; Estes L; Pardi D
Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
[No Abstract] [Full Text] [Related]
13. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
Chihara S; Shimizu R; Furukata S; Hoshino K
Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
15. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Bossé D; Lemire C; Ruel J; Cantin AM; Ménard F; Valiquette L
Infection; 2013 Apr; 41(2):579-82. PubMed ID: 22996384
[TBL] [Abstract][Full Text] [Related]
16. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Bateman BT; Rassen JA; Schneeweiss S; Bykov K; Franklin JM; Gagne JJ; Polinski JM; Liu J; Kulik A; Fischer MA; Choudhry NK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):472-8. PubMed ID: 23541855
[TBL] [Abstract][Full Text] [Related]
18. [Clostridium difficile toxin-associated diarrhea in geriatrics].
Hager K; Ruwe A
Z Gerontol Geriatr; 1998 Feb; 31(1):16-21. PubMed ID: 9553219
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
[TBL] [Abstract][Full Text] [Related]
20. Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
Wenisch JM; Schmid D; Kuo HW; Allerberger F; Michl V; Tesik P; Tucek G; Laferl H; Wenisch C
Antimicrob Agents Chemother; 2012 Apr; 56(4):1974-8. PubMed ID: 22252830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
